SPECIAL NOTICE
A -- Intent to Announce RPP 18-04 of MCDC OTA
- Notice Date
- 2/8/2018
- Notice Type
- Special Notice
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of the Army, Army Contracting Command, ACC - NJ (W15QKN), BUILDING 10 PHIPPS RD, PICATINNY ARSENAL, New Jersey, 07806-5000, United States
- ZIP Code
- 07806-5000
- Solicitation Number
- W15QKN-18-Z-01HY
- Point of Contact
- Vincent Samuel Conca,
- E-Mail Address
-
vincent.s.conca.civ@mail.mil
(vincent.s.conca.civ@mail.mil)
- Small Business Set-Aside
- N/A
- Description
- This is not a Request for Prototype Proposals, but for planning purposes only. A project award will not be awarded from this announcement. The Government intends to announce one Request for Prototype Proposals (RPP 18-04) for execution of a project award(s) in support of Medical Countermeasure Systems Research and Development related to specified project requirements. The purpose of this announcement is to provide members of the Medical CBRN Defense Consortium, and industry in general, advanced notification of Government intent. On 08 April 2016, the Government entered into an Other Transaction Agreement (OTA) with one (1) consortium, the Medical CBRN Defense Consortium (MCDC), in support of Medical Countermeasure Systems related research and development prototype projects. It is the intent of the Government to make project award(s) to member(s) of the MCDC as a result of member project proposals submitted via the Request for Prototype Proposals process. RPP 18-04 The Government anticipates seven (7) projects for white papers and full proposals to be solicited via W15QKN-16-9-1002 - consisting of the following: 1. Assay Development for the Identification of Markers of Venezuelan Equine Encephalitis Virus Infection in Animal Models. 2. Multiplex Vertical flow Paper-based Immunoassay (VPI) Diagnostic System. 3. Francisella tularensis Immune Assays. 4. Burkholderia Species Immune Assays. 5. Prophylaxis/Pretreatment Against Francisella tularensis. 6. Next Generation Devices for Delivery of Nucleic Acid Vaccines. 7. Point-of-Care Diagnostics to identify the Causative Agents for Melioidosis and the Plague. In order to obtain more information regarding the above projects, you must be a member of the Medical CBRN Defense Consortium (MCDC), www.medcbrn.org. For more information regarding membership or general questions to the MCDC, contact Michael Stebbins, at 843-760-4094 or mcdc@ati.org.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/notices/6bf181109e877fac44c6ff1b29b67c20)
- Record
- SN04817604-W 20180210/180208231903-6bf181109e877fac44c6ff1b29b67c20 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |